As shown in the Kaplan–Meier curves, sarcopenia cases showing IL-16 upregulation displayed the poorest prognosis, while patients without sarcopenia and IL-16 downregulation displayed the most favorable survival (p < 0.001 upon log-rank test) (Figure 2). The gene discussed is IL16; the disease is sarcopenia.